文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

一种整合癌胚抗原水平的预后列线图,用于预测老年II-III期结直肠癌患者的总生存期。

A prognostic nomogram integrating carcinoembryonic antigen levels for predicting overall survival in elderly patients with stage II-III colorectal cancer.

作者信息

Zhang Haijiao, Wang Rangrang, Yu Tianyu, Yu Dingye, Song Changfeng, Ma Bingwei, Li Jiyu

机构信息

Department of General Surgery, Huadong Hospital Affiliated to Fudan University, Shanghai, China.

Department of General Surgery, Shanghai Tenth People's Hospital of Tongji University, Tongji University, Shanghai, China.

出版信息

J Gastrointest Oncol. 2024 Feb 29;15(1):164-178. doi: 10.21037/jgo-23-863. Epub 2024 Feb 27.


DOI:10.21037/jgo-23-863
PMID:38482246
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10932663/
Abstract

BACKGROUND: With the aging of the population, colorectal surgeons will have to face more elderly colorectal cancer (CRC) patients in the future. We aim to analyze independent risk factors affecting overall survival in elderly (age ≥65 years) patients with stage II-III CRC and construct a nomogram to predict patient survival. METHODS: A total of 3,016 elderly CRC patients with stage II-III were obtained from the SEER database. Univariate Cox regression and the least absolute shrinkage and selection operator (LASSO) regression analyses were used to screen independent prognostic factors, and a survival prediction nomogram was constructed based on the results. The consistency index (C-index), decision curve analysis (DCA), Akaike information criterion (AIC), and Bayesian information criterion (BIC) were used to compare the predictive ability between the nomogram and tumor-node-metastasis (TNM) stage system. All patients were classified into high-risk and low-risk groups based on risk scores calculated by nomogram. The Kaplan-Meier method was used to compare the survival differences between two groups. RESULTS: The 3- and 5-year area under the curve (AUC) values of the prediction nomogram model were 76.6% and 74.8%, respectively. The AIC, BIC, and C-index values of the nomogram model were 6,032.502, 15,728.72, and 0.707, respectively, which were better than the TNM staging system. Kaplan-Meier survival analysis showed a significant survival difference between high-risk and low-risk groups (P<0.0001). CONCLUSIONS: We constructed a prediction nomogram for stage II-III elderly CRC patients by combining pre-treatment carcinoembryonic antigen (CEA) levels, which can accurately predict patient survival. This facilitates clinicians to accurately assess patient prognosis and identify high-risk patients to adopt more aggressive and effective treatment strategies.

摘要

背景:随着人口老龄化,结直肠外科医生未来将面对更多老年结直肠癌(CRC)患者。我们旨在分析影响老年(年龄≥65岁)II-III期CRC患者总生存的独立危险因素,并构建列线图以预测患者生存。 方法:从监测、流行病学与最终结果(SEER)数据库中获取3016例老年II-III期CRC患者。采用单因素Cox回归和最小绝对收缩和选择算子(LASSO)回归分析筛选独立预后因素,并根据结果构建生存预测列线图。使用一致性指数(C指数)、决策曲线分析(DCA)、赤池信息准则(AIC)和贝叶斯信息准则(BIC)比较列线图与肿瘤-淋巴结-转移(TNM)分期系统之间的预测能力。根据列线图计算的风险评分将所有患者分为高风险和低风险组。采用Kaplan-Meier法比较两组之间的生存差异。 结果:预测列线图模型的3年和5年曲线下面积(AUC)值分别为76.6%和74.8%。列线图模型的AIC、BIC和C指数值分别为6032.502、15728.72和0.707,均优于TNM分期系统。Kaplan-Meier生存分析显示高风险和低风险组之间存在显著的生存差异(P<0.0001)。 结论:我们通过结合治疗前癌胚抗原(CEA)水平构建了II-III期老年CRC患者的预测列线图,可准确预测患者生存。这有助于临床医生准确评估患者预后并识别高风险患者,从而采取更积极有效的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/10932663/da98b6b29b83/jgo-15-01-164-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/10932663/0b713257d6f3/jgo-15-01-164-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/10932663/8215c971a6ff/jgo-15-01-164-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/10932663/403f54481577/jgo-15-01-164-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/10932663/16263623ab36/jgo-15-01-164-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/10932663/7003afe39571/jgo-15-01-164-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/10932663/3063de6129e4/jgo-15-01-164-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/10932663/da98b6b29b83/jgo-15-01-164-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/10932663/0b713257d6f3/jgo-15-01-164-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/10932663/8215c971a6ff/jgo-15-01-164-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/10932663/403f54481577/jgo-15-01-164-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/10932663/16263623ab36/jgo-15-01-164-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/10932663/7003afe39571/jgo-15-01-164-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/10932663/3063de6129e4/jgo-15-01-164-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/10932663/da98b6b29b83/jgo-15-01-164-f7.jpg

相似文献

[1]
A prognostic nomogram integrating carcinoembryonic antigen levels for predicting overall survival in elderly patients with stage II-III colorectal cancer.

J Gastrointest Oncol. 2024-2-29

[2]
Development and validation of a prognostic nomogram for colorectal cancer after surgery.

World J Clin Cases. 2021-7-26

[3]
Nomogram for predicting overall survival in stage II-III colorectal cancer.

Cancer Med. 2020-4

[4]
The clinical value of a nomogram constructed from CEA, CA199, PT, FIB, tumor differentiation and TNM stage in colorectal cancer.

Cancer Biomark. 2023

[5]
A LASSO-based survival prediction model for patients with synchronous colorectal carcinomas based on SEER.

Transl Cancer Res. 2022-8

[6]
Elderly patients over 80 years undergoing colorectal cancer resection: Development and validation of a predictive nomogram for survival.

World J Gastrointest Surg. 2023-5-27

[7]
The value of F-FDG PET/CT-based radiomics in predicting perineural invasion and outcome in non-metastatic colorectal cancer.

Abdom Radiol (NY). 2022-4

[8]
A novel nutrition-related nomogram for the survival prediction of colorectal cancer-results from a multicenter study.

Nutr Metab (Lond). 2023-1-4

[9]
Prognostic Value of Tumor Deposit Counts in Patients with Stage III Colorectal Cancer: A Population-Based Study.

J Invest Surg. 2022-7

[10]
Development and validation of a prognostic nomogram for breast cancer patients who underwent chemoradiotherapy and surgery: a retrospective cohort study based on the SEER database and two Chinese cohorts.

Am J Cancer Res. 2023-11-15

引用本文的文献

[1]
Insights and recommendations for enhancing the prognostic nomogram in elderly patients with stage II-III colorectal cancer.

J Gastrointest Oncol. 2024-8-31

[2]
Relationships of SIGLEC family-related lncRNAs with clinical prognosis and tumor immune microenvironment in ovarian cancer.

Sci Rep. 2024-3-31

本文引用的文献

[1]
Estimating the economic burden of colorectal cancer in China, 2019-2030: A population-level prevalence-based analysis.

Cancer Med. 2024-1

[2]
A recurrence-predictive model based on eight genes and tumor mutational burden/microsatellite instability status in Stage II/III colorectal cancer.

Cancer Med. 2024-1

[3]
Long-term outcomes in elderly patients after elective surgery for colorectal cancer within an ERAS protocol: a retrospective analysis.

Langenbecks Arch Surg. 2023-11-17

[4]
Robotic surgery in elderly patients with colorectal cancer: Review of the current literature.

World J Gastrointest Surg. 2023-6-27

[5]
Elderly patients over 80 years undergoing colorectal cancer resection: Development and validation of a predictive nomogram for survival.

World J Gastrointest Surg. 2023-5-27

[6]
High preoperative CEA and systemic inflammation response index (C-SIRI) predict unfavorable survival of resectable colorectal cancer.

World J Surg Oncol. 2023-6-9

[7]
Young-onset colorectal cancer.

Nat Rev Dis Primers. 2023-4-27

[8]
Colorectal cancer statistics, 2023.

CA Cancer J Clin. 2023

[9]
Current Targeted Therapy for Metastatic Colorectal Cancer.

Int J Mol Sci. 2023-1-15

[10]
Immunotherapy: Recent Advances and Its Future as a Neoadjuvant, Adjuvant, and Primary Treatment in Colorectal Cancer.

Cells. 2023-1-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索